Published in J Neuroinflammation on February 03, 2015
Neurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53. PLoS One (2015) 0.78
Systemic Escherichia coli infection does not influence clinical symptoms and neurodegeneration in experimental autoimmune encephalomyelitis. BMC Neurosci (2015) 0.77
Retracted Resistant Strains of Enterotoxigenic Staphylococcus aureus; Unknown Risk for Multiple Sclerosis Exacerbation. Iran Red Crescent Med J (2015) 0.75
Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol (1952) 8.13
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature (1992) 7.20
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2010) 5.10
Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol (2007) 5.01
Clinical viral infections and multiple sclerosis. Lancet (1985) 3.12
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol (1998) 2.97
Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain (2002) 2.89
Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A (2003) 2.50
Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat Med (2002) 1.92
The genetics of multiple sclerosis: an up-to-date review. Immunol Rev (2012) 1.74
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1990) 1.68
The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses. J Clin Invest (2002) 1.63
Assessing and managing risk when sharing aggregate genetic variant data. Nat Rev Genet (2011) 1.62
Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology (2003) 1.57
Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis. Brain Pathol (2004) 1.45
Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol (1993) 1.44
Acute neuronal apoptosis in a rat model of multiple sclerosis. J Neurosci (2001) 1.37
Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. BMJ (2003) 1.32
The anti-inflammatory activities of Staphylococcus aureus. Trends Immunol (2007) 1.29
Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions. FEBS J (2006) 1.24
Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol (1995) 1.23
Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus. J Exp Med (2006) 1.17
The adhesive and immunomodulating properties of the multifunctional Staphylococcus aureus protein Eap. Microbiology (2003) 1.16
Systemic inflammation induces axon injury during brain inflammation. Ann Neurol (2011) 1.13
Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neurosci (2003) 1.11
Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J Immunol (2005) 1.08
Lipopolysaccharide injection induces relapses of experimental autoimmune encephalomyelitis in nontransgenic mice via bystander activation of autoreactive CD4+ cells. J Immunol (2005) 1.06
Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study. Am J Pathol (2006) 1.06
Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation. Neurobiol Dis (2007) 1.05
eap Gene as novel target for specific identification of Staphylococcus aureus. J Clin Microbiol (2007) 1.03
Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry (1998) 1.01
Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol (1993) 1.01
Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A (1993) 1.00
Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis. J Neuroimmunol (1993) 1.00
Bacterial agents protect against autoimmune disease. I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis. J Autoimmun (1992) 0.95
Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo. Eur J Immunol (2002) 0.94
Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2. Infect Immun (2006) 0.91
Chlamydia pneumoniae infection of the central nervous system worsens experimental allergic encephalitis. J Exp Med (2002) 0.90
Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil (1996) 0.89
Anti-inflammatory effects of FTY720 do not prevent neuronal cell loss in a rat model of optic neuritis. Am J Pathol (2011) 0.89
Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue. Mult Scler (2002) 0.85
Extracellular adherence protein of Staphylococcus aureus suppresses disease by inhibiting T-cell recruitment in a mouse model of psoriasis. J Invest Dermatol (2009) 0.81
Previous infection with Staphylococcus aureus strains attenuated experimental encephalomyelitis. BMC Neurosci (2014) 0.80
Effects of staphylococcal enterotoxin B on T cell receptor V beta utilization and clinical manifestations of experimental allergic encephalomyelitis. J Neuroimmunol (1993) 0.80
Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D. Cell Immunol (1993) 0.78
Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen. Proc Natl Acad Sci U S A (1995) 0.78
Preventing postoperative Staphylococcus infections: an update. Surg Technol Int (2003) 0.77